FATE THERAPEUTICS INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $384.4M | $167.3M |
| FY2021 | — | $678.8M | $133.6M |
| FY2022 | — | $483.9M | $61.3M |
| FY2023 | — | $368.4M | $41.9M |
| FY2024 | — | $318.7M | $36.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $384.4M | $167.3M |
| FY2021 | — | $678.8M | $133.6M |
| FY2022 | — | $483.9M | $61.3M |
| FY2023 | — | $368.4M | $41.9M |
| FY2024 | — | $318.7M | $36.1M |